Opti Liv Extra
Natural health product licensed in Canada
- Other names
- Liver Synergy
- Licence holder
- Optimum Health Vitamins & More
- NPN or DIN-HM
- 80047691
- Status
- Active licence
- Licence date
- 20 January 2014
- Revision date
- 25 April 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 150 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Schisandra chinensis Source : Fruit | 150 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 50 mcg | 150 µg |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 100 mg | Not calculated |
| Silybum marianum Source : Graine(s) Potency : 80 % Silymarin | 250 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, N-acétyl-L-cystéine, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | minimum: 1 day ; maximum: 3 days |
Uses authorised in Canada
(Traditionally used in Herbal Medicine as a) hepatoprotectant/ liver protectant.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes or a history of non-melanoma skin cancer.
- Effets indésirables connus
Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80047691
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging